Abstract:AIM:To study the mechanism of absorption after oral administration of panaxnotoginseng saponins (PNS).METHODS:Caco-2 cells and rat models were applied to evaluate the degradation of both ginsenoside Rb1 (Rb1) and ginsenoside Rg1 (Rg1) in PNS in gastrointestinal lumen, and the transport mechanism of PNS across the intestinal mucosa, and the barrier function of stomach, intestine and liver involved in absorption process.RESULTS:Rb1 and Rg1 proved to be readily eliminated in stomach, but stable in relatively neutral circumstance. Both Rb1 and Rg1 in PNS, especially for Rb1, degraded significantly in the contents of large intestine. However, both of them kept mainly intact in the contents of small intestine. Uptake of both Rb1 and Rg1 by Caco-2 cell monolayer was inhibited at low temperature, but not by cyclosporine A, and the change in the apical pH showed no pronounced effect. Uptake and transport were non-saturable and increased linearly with increasing of concentrations of Rb1 and Rg1 over the range of concentration tested, which indicated a passive transport. There was no significant difference of absorption characteristic between monomer (Rb1 and Rg1) and mixture (PNS). Uptake amount of Rg1 [(1.07 +/- 0.16) microg x mg(-1) (protein)] (C0 = 1 mg x mL(-1)) in Caco-2 cells was a little higher than that of Rb1 [(0.77 +/- 0.03) microg x mg(-1) (protein)] (C0 = 1 mg x mL(-1)). Meanwhile, apparent permeability coefficient of (5.9 +/- 1.0) x 10(-8) cm x s(-1) (C0 = 1 mg x mL(-1)) for Rb1 and (2.59 +/- 0.17) x 10(-7) cm x s(-1) (C0 = 1 mg x mL(-1)) for Rg1 from apical compartment to basolateral compartment predicted an incompletely absorption. Transports of both Rb1 and Rg1 were not influenced by cyclosporine A. The investigation on the pharmacokinetic behavior of Rb1 and Rg1 after different routes of administration to rats showed that the absolute bioavailability after peroral (po), intraduodenal (id), and portal venous (pv) administration is 0.71% , 2.75% and 65.77% respectively for Rb1, and 3.29%, 6.60% and 50.56% respectively for Rg1.CONCLUSION:Transport across Caco-2 cell monolayer for PNS (include Rb1 and Rg1) is a simple passive diffusion process. No efflux transporters in Caco-2 cells and other components in PNS showed effects on it. The elimination in stomach, large intestine and liver contributed to the low bioavailability of PNS, but the low membrane permeability might be a more important factor dominating the extent of absorption.

The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats

The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats

[Comparison Between the Characteristics of Absorption and Pharmacokinetic Behavior of Ginsenoside Rg1 and Ginsenoside Rb, of Panax Notoginseng Saponins].

Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng.

Improvement of Oral Availability of Ginseng Fruit Saponins by a Proliposome Delivery System Containing Sodium Deoxycholate

Influence of Glycerol/Watersolution on Ginsenosides Rg1Bioavailability in rats

Enhanced Oral Bioavailability of Mangiferin Phospholipid Complexes Prepared by Its Oil-Based Formulations in Rats

Influence of Glycerol/Dimethylsulfoxide Homogeneous Solution on PNS Bioavailability in rats

[Screening of Panax Notoginsenoside Water in Oil Microemulsion Formulations and Their Evaluation in Vitro and in Vivo].

Pharmacokinetics Study of Bio-Adhesive Tablet of Panax Notoginseng Saponins.

Panax Notoginseng Saponin Liposomes:Characterization of Pharmaceutics and Pharmacokinetics on Pulmonary Instillation in Rats

Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides

Preparation and Evaluation of Lecithin/zein Hybrid Nanoparticles for the Oral Delivery of Panax Notoginseng Saponins.

Effects of Compound Compatibility on Biopharmaceutical Characteristics of Panaxnotoginseng Saponins

Self-Double-Emulsifying Drug Delivery System Enteric-Coated Capsules: A Novel Approach to Improve Oral Bioavailability and Anti-inflammatory Activity of Panax notoginseng Saponins

Study on preparation and transdermal drug delivery of saponins of panax notoginseng compound liposomal gel

[Mechanism of Oral Absorption of Panaxnotoginseng Saponins].

Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panaxnotoginseng in rats

Preparation of Panax notoginseng flower saponins enteric-coated sustained-release pellets and its pharmacokinetics and in vitro-in vivo correlation

Notoginseng Noside Liposomes:Preparation and Physiological Compatibility Study

Preparation and In Vitro and In Vivo Evaluation Of Panax Notoginseng Saponins-loaded Nanoparticles Coated with Trimethyl Chitosan Derivatives